Most recently I have again turned slightly bullish. I will post my latest narrative soon on Abbott. I am also excited with upcoming Mankind pharma ipo. I have written off Eris because I am not convinced with management’s capital allocation abilities. I might sell tracking position soon. That’s a first ‘Sell’ or trim since the start of this thread
Subscribe To Our Free Newsletter |